Revitope

Revitope

Biotechnology Research Cambridge, Massachusetts, United States 7 employees
Employees
7
Contacts
2
Emails
2
Phones
1

Revitope Overview

Headquarters
Cambridge, Massachusetts, United States
Website
revitope.com
Industry
Biotechnology Research
Employees
7
Founded
2016
Funding
8.5M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Revitope

Revitope is an early stage biotechnology company focused on developing the next-generation of T cell redirecting biologics. Immune-based therapies are redefining how cancer is treated as clinical studies demonstrate unprecedented deep and durable responses in multiple cancers. In particular redirecting T cells to tumors is a successful strategy for immunotherapy of liquid tumors. However, unleashing a potent immune response that is entirely focused on the tumor continues to be elusive. Revitope is developing a new class of biologic prodrugs we call Programmable Antibody Circuits or PACs that are engineered to focus immune activation to the cancer cell surface while expanding the antigenic targeting space.

Revitope Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
1
25.0% coverage

Revitope Org Chart

Sample employees and titles
Name Title Contact
Mark Cobbold SVP, Io Discovery & Cell Therapy
View
Raj Mehta CEO, Adendra Therapeutics
View
Carsten Reinhardt Ever Curious
Email
Andrew Allen Executive Chairman at Peptone
Email Phone

Employees by Management Level

Individual contributor 3 profiles
Executive 2 profiles

Compare Similar Companies to Revitope